| COVID-19 |
1 |
1 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.79 |
| Clinical Guidelines |
0 |
0.35 |
| Fatigue |
0 |
0.33 |
| Treatment Guidelines |
0 |
0.32 |
| Exercise |
0 |
0.25 |
| Brain |
0 |
0.15 |
| Physical Medicine and Rehabilitation (PMR) |
0 |
0.15 |
| Healthcare and Medical Technology |
0 |
0.09 |
| Sleep Disorders |
0 |
0.09 |
| Blood |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Primary Care |
0 |
0.08 |
| Sleep |
0 |
0.08 |
| Cerebrovascular Accident |
0 |
0.07 |
| Thromboembolism |
0 |
0.07 |
| Thrombus |
0 |
0.07 |
| Traumatic Brain Injury |
0 |
0.07 |
| Myalgia |
0 |
0.06 |
| Cancer |
0 |
0.05 |
| Heart |
0 |
0.05 |
| Muscle |
0 |
0.05 |
| Pain Management |
0 |
0.05 |
| Parkinson Disease |
0 |
0.05 |
| Stress |
0 |
0.05 |
| Acupuncture |
0 |
0.03 |
| Antiviral Agents |
0 |
0.03 |
| Anxiety |
0 |
0.03 |
| Anxiety Disorder |
0 |
0.03 |
| California |
0 |
0.03 |
| Chronic Fatigue Syndrome |
0 |
0.03 |
| Complementary and Alternative Medicine |
0 |
0.03 |
| Dementia |
0 |
0.03 |
| Depression |
0 |
0.03 |
| Dietary Supplements |
0 |
0.03 |
| Headache |
0 |
0.03 |
| Injury |
0 |
0.03 |
| Lung |
0 |
0.03 |
| Memory |
0 |
0.03 |
| Mood Disorders |
0 |
0.03 |
| Movement Disorder |
0 |
0.03 |
| Multiple Sclerosis |
0 |
0.03 |
| Narcolepsy |
0 |
0.03 |
| Nutrition |
0 |
0.03 |
| Pain |
0 |
0.03 |
| Pennsylvania |
0 |
0.03 |
| Prescription Drugs |
0 |
0.03 |
| Referral |
0 |
0.03 |
| Stimulants |
0 |
0.03 |
| Texas |
0 |
0.03 |
| Washington |
0 |
0.03 |
| Wound Management |
0 |
0.03 |